Plasma levels of trimipramine and metabolites in four patients: determination of the enantiomer concentrations of the hydroxy metabolites.
A two-step high-performance liquid chromatography method is described, using a CN column and an alpha 1-acid glycoprotein column, which allows the measurement of the enantiomers of the hydroxy metabolites of trimipramine in plasma of trimipramine-treated patients. Of the four patients analyzed, three showed approximately equimolar concentrations of the (D)- and (L)-enantiomers of the hydroxy metabolites (2-hydroxy-trimipramine and 2-hydroxy desmethyltrimipramine), and one was found to have roughly twice as much of the (L)-form and of the (D)-form of 2-hydroxy trimipramine and 2-hydroxy desmethyltrimipramine. From the data available on the pharmacological effects of the enantiomers of trimipramine, it is postulated that this interindividual variability in its pharmacokinetics is another factor that could contribute to the interindividual variability in its pharmacodynamics.
Eap
C B
CB
Département Universitaire de Psychiatrie Adulte (DUPA), Hôpital de Cery, Lausanne, Switzerland.
Koeb
L
L
Holsboer-Trachsler
E
E
Baumann
P
P
D002851:Chromatography, High Pressure Liquid / Q000379:methods; D006801:Humans; D009961:Orosomucoid; D013237:Stereoisomerism; D014299:Trimipramine / Q000031:analogs & derivatives / Q000097:blood* / Q000378:metabolism*
D009961:Orosomucoid; C078397:2-hydroxydesmethyltrimipramine; C070661:2-hydroxytrimipramine; D014299:Trimipramine; C040606:desmethyltrimipramine